Cytosorbents Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cytosorbents Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2024.
  • Cytosorbents Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $48.3M, a 6.47% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $48.3M +$2.93M +6.47% Dec 31, 2024 10-K 2025-03-31
Q4 2023 $45.3M +$6.03M +15.3% Dec 31, 2023 10-K 2025-03-31
Q4 2022 $39.3M +$8.06M +25.8% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $31.2M +$6.45M +26% Dec 31, 2021 10-K 2024-03-15
Q4 2020 $24.8M +$1.94M +8.47% Dec 31, 2020 10-K 2023-03-09
Q4 2019 $22.9M +$4.62M +25.4% Dec 31, 2019 10-K 2022-03-10
Q4 2018 $18.2M +$4.09M +28.9% Dec 31, 2018 10-K 2021-03-09
Q4 2017 $14.1M -$3M -17.5% Dec 31, 2017 10-K 2020-03-05
Q4 2016 $17.2M +$2.41M +16.3% Dec 31, 2016 10-K 2019-03-07
Q4 2015 $14.7M +$3.67M +33.2% Dec 31, 2015 10-K 2018-03-08
Q4 2014 $11.1M Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.